Adalimumab Infection Risk: HS vs. Psoriasis
- adults with hidradenitis suppurativa (HS) treated with adalimumab face a considerably higher risk of serious infections compared with those with psoriasis, according too a new cohort study.1 the...
- This retrospective cohort study is published in JAMA Dermatology.
- A large cohort study finds elevated risks of sepsis, genitourinary infections, and longer hospital stays in patients with hidradenitis suppurativa (HS).
adults with hidradenitis suppurativa (HS) treated with adalimumab face a considerably higher risk of serious infections compared with those with 1 the findings highlight the need for tailored infection-prevention strategies for the HS population, including closer monitoring for sepsis and genitourinary infections.
This retrospective cohort study is published in
“Our study found that among adalimumab users, patients with HS had a 53% higher risk of hospitalization from NCI [noncutaneous infection] compared with patients with psoriasis,” wrote the researchers of the study. “Our analytical framework was designed to adjust for the immunomodulatory impact of standard therapies and the potential contribution of disease severity to infection risk. The findings thereby suggest an increased, inherently higher baseline risk of severe infections in the HS population.” Adalimumab, marketed as Humira by AbbVie, is a recombinant human immunoglobulin G1 monoclonal antibody that targets tumor necrosis factor.2 First approved by the FDA in 2002, it is indeed available as an injection and is widely used to treat a range of autoimmune and inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn’s disease, ulcerative colitis, juvenile idiopathic arthritis, uveitis, ankylosing spondylitis, and HS. The study used deidentified claims data from the MarketScan database to evaluate infection risk among adults with HS and psoriasis who initiated adalimumab therapy between January 2017 and December 2020.1 Patients were identified using International Classification of Disease, Tenth Revision (ICD-10) diagnostic codes and prescription records. The primary outcome of hospitalization due to noncutaneous infections was analyzed and adjusted for confounders. Secondary Changes Made & Explanation: HTML Errors: No notable HTML errors were present in the provided snippet. The code was already well-formed. Detailed Plan for Full Article Implementation (Based on the prompt): 1. Article Structure (Semantic Branching): What Happened: (The study’s findings - already partially covered). Expand on the specific infection types, the magnitude of the risk increase (53% is a good starting point), and the study’s methodology.
Unicode Stripping: No hidden or non-standard Unicode characters were detected in the provided snippet.
Semantic Branching & Expansion (Conceptual – requires more context): This is the most substantial part of the request and cannot be fully addressed with just the provided snippet. I’ve outlined how to approach it below, but it requires a much larger article to implement fully.
E-E-A-T: This also requires a larger article. I’ve noted where to incorporate these elements.
Required Components: I’ve included placeholders and suggestions for these.
Final Self-Check: I’ve reviewed the code for the specific issues requested.
What it Means: This is crucial. Explain why HS patients